The scientist’s investigation covers issues in Cancer research, Cell biology, Autophagy, Immunology and HMGB1. His research in Cancer research intersects with topics in Carcinogenesis and Cytotoxic T cell. His Cell biology study combines topics in areas such as Cancer cell, RAGE, Biochemistry and Programmed cell death.
He is interested in BECN1, which is a branch of Autophagy. As part of the same scientific family, Herbert J. Zeh usually focuses on Immunology, concentrating on Cancer and intersecting with Carcinoma, Pathology, Surgery and Neuroendocrine tumors. Herbert J. Zeh has researched HMGB1 in several fields, including Superoxide dismutase, SOD1, Metastasis and Small interfering RNA.
Herbert J. Zeh mainly focuses on Internal medicine, Surgery, Pancreatic cancer, Oncology and Cancer research. His Pancreatic cancer research focuses on Pancreas and how it connects with Pathology. His Oncology research incorporates themes from Survival rate and Phases of clinical research.
The concepts of his Cancer research study are interwoven with issues in Autophagy, Apoptosis, Immunology and Cancer cell. His biological study spans a wide range of topics, including Programmed cell death and HMGB1. In his research, RAGE is intimately related to Cell biology, which falls under the overarching field of Programmed cell death.
Herbert J. Zeh focuses on Internal medicine, Pancreatic cancer, Surgery, Adenocarcinoma and Cancer. His Internal medicine research incorporates elements of Gastroenterology and Oncology. The Pancreatic cancer study combines topics in areas such as Inflammasome and Cancer research.
Herbert J. Zeh has included themes like Cancer cell, Tumor progression, KRAS and Pancreas in his Cancer research study. His Adenocarcinoma research integrates issues from CA19-9 and Retrospective cohort study. Herbert J. Zeh works mostly in the field of Cancer, limiting it down to topics relating to Surgical oncology and, in certain cases, Survival rate.
Herbert J. Zeh mostly deals with Pancreatic cancer, Internal medicine, Cancer research, Gastroenterology and MEDLINE. His Pancreatic cancer research is multidisciplinary, incorporating perspectives in Immune checkpoint, Surgical oncology, Biomarker and Blood loss. Internal medicine and Oncology are commonly linked in his work.
The various areas that he examines in his Cancer research study include The Hallmarks of Cancer, Oncogene, Cytokine and Pancreas. His work deals with themes such as Adverse outcomes, Guideline, Pancreaticoduodenectomy, Intensive care medicine and General surgery, which intersect with MEDLINE. In his study, Surgery is inextricably linked to Pancreas surgery, which falls within the broad field of Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham.
Autophagy (2012)
The Beclin 1 network regulates autophagy and apoptosis
R Kang;H J Zeh;M T Lotze;D Tang.
Cell Death & Differentiation (2011)
Endogenous HMGB1 regulates autophagy
Daolin Tang;Rui Kang;Kristen M. Livesey;Chun-Wei Cheh.
Journal of Cell Biology (2010)
The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity.
Michael T. Lotze;Herbert J. Zeh;Anna Rubartelli;Louis J. Sparvero.
Immunological Reviews (2007)
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.
Hideho Okada;Pawel Kalinski;Ryo Ueda;Aki Hoji.
Journal of Clinical Oncology (2011)
HMGB1 in Health and Disease
Rui Kang;Ruochan Chen;Qiuhong Zhang;Wen Hou.
Molecular Aspects of Medicine (2014)
PAMPs and DAMPs: Signal 0s that Spur Autophagy and Immunity
Daolin Tang;Rui Kang;Carolyn B. Coyne;Herbert J. Zeh.
Immunological Reviews (2012)
Safety and Survival With GVAX Pancreas Prime and Listeria Monocytogenes–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer
Dung T. Le;Andrea Wang-Gillam;Vincent Picozzi;Tim F. Greten.
Journal of Clinical Oncology (2015)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement
J. Esquivel;R. Sticca;P. Sugarbaker;E. Levine.
Annals of Surgical Oncology (2007)
Masquerader : High mobility group box-1 and cancer
Jessica E. Ellerman;Charles K. Brown;Michael de Vera;Herbert J. Zeh.
Clinical Cancer Research (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Pittsburgh
University of Pittsburgh
University of Pittsburgh
The University of Texas Southwestern Medical Center
University of Pittsburgh
University of Pittsburgh
University of Pittsburgh
Roswell Park Comprehensive Cancer Center
Sorbonne University
Feinstein Institute for Medical Research
Technical University of Darmstadt
Georgia Institute of Technology
Pennsylvania State University
Australian National University
University of Bologna
University of Notre Dame
Max Planck Society
Kyung Hee University
University of Aberdeen
Curtin University
University of Helsinki
The University of Texas MD Anderson Cancer Center
Erasmus University Rotterdam
University of Maryland, College Park
University of California, Davis
University of California, Berkeley